← All IPOs

Phychem Technologies IPO Allotment Status

SMEListed
PHYCHEM · · BSE SME

Updated · GMP, subscription and listing data refresh through the day.

Phychem Technologies IPO Details

RegistrarMUFG Intime India Private Limited
Lead managersHem Securities Limited
Offer documentDraft (DRHP)
Fresh issue₹14.58 Cr
Offer for sale—
Market cap at the offer₹55.296 Cr

Market capitalisation is the post-issue share count in the offer document’s capital structure (1,02,40,000 shares) multiplied by the upper end of the price band, ₹54. It is arithmetic on those two filed figures, not a valuation.

Phychem Technologies Financials ₹ in crore

Revenue CAGR+9.9%2024 → 2026 · 2 yrs
Profit CAGR+55.6%2024 → 2026 · 2 yrs
Expenses CAGR+7.2%2024 → 2026 · 2 yrs
Total assets CAGR+19.2%2024 → 2026 · 2 yrs
00%253%505%758%10010%202420252026
₹ crore202420252026
Revenue₹47.59₹51.11₹57.48
Expenses₹45.22₹47.33₹51.94
Net profit (PAT)₹1.69₹2.84₹4.09
PAT margin3.6%5.6%7.1%
Total assets₹17.83₹20.75₹25.32

Phychem Technologies Shareholding before & after the IPO

Before the IPO
Pre-issue · RHP capital structure
100%
Promoter
After the IPO
Post-issue · as disclosed in the RHP
73.63%
Promoter
Promoter & promoter groupafter the IPO
Holding73.63%
Shares75,40,000
Through the IPO-26.37% · exiting

The founding owners and their group entities.

The post-issue ring is the register this issue’s RHP discloses. Pre-issue register from the RHP capital structure, cross-checked against exchange data. Pre-issue percentages are taken from the disclosure, never estimated.

Phychem Technologies IPO Lot Size & Minimum Investment by investor category

ApplicationSharesAmount at ₹54
Individual investor (min)minimum application4,000₹2,16,000

The minimum application is 4,000 shares, ₹2,16,000 at the ₹54 cut-off. Since 1 July 2025 SME issues take a minimum application of ₹2,00,000 or more from individual investors; the HNI minimum is set in the RHP. Amounts are shown at the upper band because applications are made at the cut-off price.

Phychem Technologies IPO Strengths & Risks as disclosed in the DRHP

▲ Strengths (5)
The company offers a wide range of roto moulding compounds with diverse applications.
The company has long-standing relationships with diversified customers across geographies.
The company possesses an in-house manufacturing facility with equipped machines and processes.
The company focuses on quality, environment, health, and safety.
The company benefits from experienced promoters and management with extensive domain knowledge.
▼ Risk factors (8)
The company's business is dependent on its manufacturing facility, and any slowdown or shutdown could adversely affect operations.
A significant portion of revenue is derived from major customers, and the lack of long-term agreements poses a risk.
The company is heavily reliant on a few suppliers for raw materials, with its single largest supplier contributing over 50% of purchases.
The company derives a portion of its revenues from exports and is subject to risks of international trade.
The company faces competition from both domestic and multinational corporations, and an inability to compete effectively could have a material adverse impact.
The company's registered office and factory are situated on leased premises, and failure to renew leases could adversely affect business.
The company may be subject to increasingly stringent environmental, health, and safety laws and regulations.
Any disruption to the manufacturing facility may result in production shutdowns.

How to check Phychem Technologies IPO allotment status

Allotment is decided and published by the issue’s registrar, not by the exchange and not by alphave. For PHYCHEM TECHNOLOGIES LIMITED, the registrar is MUFG Intime India Private Limited — allotment is finalised in the days between the issue closing on 02 Sept 2026 and listing on 07 Sept 2026.

RegistrarMUFG Intime India Private Limited
You will needPAN, application number or demat ID
Issue closes02 Sept 2026
Listing date07 Sept 2026
Issue opens
Mon, 31 Aug, 2026
Bidding 10:00 am – 5:00 pm IST
Issue closes
Wed, 02 Sept, 2026
Last day to bid · UPI mandate by 5:00 pm
Allotment finalisedTentative
Thu, 03 Sept, 2026
By MUFG Intime; check with PAN, application no. or DP ID
Refunds & UPI unblockTentative
Fri, 04 Sept, 2026
Unallotted amounts released · allotted shares credited to demat
Listing
Mon, 07 Sept, 2026
BSE SME · trading from 10:00 am IST

Allotment and refund dates follow SEBI’s T+3 listing timeline in trading days and are tentative until the registrar and the exchange confirm them. alphave does not hold allotment results — only the registrar can show whether an application was allotted.

The registrar publishes allotment on its own portal: MUFG Intime. Your bank will also show the blocked amount released if shares were not allotted.

Phychem Technologies IPO Allotment Status FAQs

When is Phychem Technologies IPO allotment date?

Allotment for the Phychem Technologies Limited IPO is expected to be finalised on 3 September 2026, the trading day after the issue closes on 2 September 2026. Under SEBI's T+3 timeline refunds and demat credit follow on 4 September 2026 and the shares list on 7 September 2026. Dates are tentative until the registrar and exchange confirm them.

How to check Phychem Technologies IPO allotment status?

Allotment is decided and published by the registrar, MUFG Intime India Private Limited — not by the exchange and not by alphave. Open the registrar's IPO allotment page, choose the issue, and enter your PAN, application number or DP ID / client ID. Your bank will also show the blocked amount released if shares were not allotted.

Who is the registrar of Phychem Technologies IPO?

The registrar to the Phychem Technologies Limited IPO is MUFG Intime India Private Limited. The registrar processes applications, finalises the basis of allotment with the exchange, and handles refunds.

What happens if I do not get allotment?

The amount blocked in your bank account under ASBA or the UPI mandate is released, normally on the day allotment is finalised or the next working day. No shares are credited and nothing further is needed from you.

Phychem Technologies IPO Registrar where allotment and refund queries go

RegistrarMUFG Intime India Private Limited

The registrar processes the allotment and the refunds. Contact details are as printed in the offer document; the exchange and your broker cannot change an allotment.

How to Apply for the Phychem Technologies IPO ASBA and UPI, as SEBI sets them

  1. Apply through your broker’s IPO window or your bank’s net banking (ASBA). The money stays in your own account and is only blocked until allotment.
  2. Choose the number of lots and bid at the cut-off price. SME issues take a minimum application of two lots, so the smallest valid bid is the amount shown in the lot table above.
  3. If you applied through a broker, approve the UPI mandate in your payment app. The mandate must be approved by 5 pm on the day after your bid, and by 5 pm on the closing day for bids made on the last day (02 Sept 2026).
  4. One application per PAN. A second application under the same PAN is rejected, and both may be.
  5. After allotment the blocked amount is released for shares not allotted. Allotment and refund queries go to the registrar, MUFG Intime India Private Limited, not to the exchange or the broker.

What is GMP in an IPO?

Grey Market Premium is the price at which an unlisted IPO application or share changes hands informally, before the stock is listed on the exchange. It is quoted as a rupee figure over the issue price: a premium of ₹1 on a ₹54 upper band means the grey market is dealing at ₹55.

The grey market is an over-the-counter market between private dealers. It is not operated or supervised by NSE, BSE or SEBI, no trade is settled through a clearing corporation, and no dealer is obliged to publish or honour a quote. Figures are collected by third-party reporters and different sources routinely disagree, which is why a premium can move sharply within a day or vanish entirely once bidding closes.

Grey Market Premium is an unofficial, unregulated over-the-counter datapoint reported by third parties. It is not a price, a forecast, or an indication of listing gains, and is not investment advice.